Protara Therapeutics (1KPA.STU) Q2 2026 Earnings

13MayConfirmed
Q2 2026
-0.31
-0.3
-0.28
-0.26

Details

Expected EPS
-0.3145384914
Actual EPS
-0.264554
Surprise EPS
0.05
Surprise Percent
+15.89%

Description

Protara Therapeutics (1KPA.STU) has reported earnings of -0.264554 per share for Q2 2026.

0 Comments

Share your thoughts